FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION
Articolo
Data di Pubblicazione:
2017
Citazione:
FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION / Iacono, Pierluigi; Battaglia Parodi, Maurizio; Selvi, Federico; Parravano, Maria Cristina; Chiaravalloti, Adele; Varano, Monica; Bandello, Francesco. - In: RETINA. - ISSN 0275-004X. - 37:10(2017), pp. 1931-1941-1941. [10.1097/IAE.0000000000001436]
Abstract:
To identify the prognostic variables relative to myopic choroidal neovascularization (CNV) treated with intravitreal ranibizumab/bevacizumab.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Choroidal Neovascularization; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Intravitreal Injections; Male; Middle Aged; Myopia, Degenerative; Prognosis; Prospective Studies; Ranibizumab; Refraction, Ocular; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity
Elenco autori:
Iacono, Pierluigi; Battaglia Parodi, Maurizio; Selvi, Federico; Parravano, Maria Cristina; Chiaravalloti, Adele; Varano, Monica; Bandello, Francesco
Link alla scheda completa:
Pubblicato in: